Publication: Effect of N-terminal truncation on antibacterial activity, cytotoxicity and membrane perturbation activity of Cc-CATH3
dc.contributor.author | Jiraphun Jittikoon | en_US |
dc.contributor.author | Narumon Ngamsaithong | en_US |
dc.contributor.author | Jutarat Pimthon | en_US |
dc.contributor.author | Opa Vajragupta | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.date.accessioned | 2018-11-23T09:37:39Z | |
dc.date.available | 2018-11-23T09:37:39Z | |
dc.date.issued | 2015-10-01 | en_US |
dc.description.abstract | © 2015 The Pharmaceutical Society of Korea. A series of amino-terminal truncated analogues of quail antimicrobial peptide Cc-CATH3(1-29) were created and examined antibacterial activity against Gram-positive bacteria, cytotoxicity against mouse fibroblast cell line, and membrane perturbation activity against various membrane models. Parent peptide Cc-CATH3(1-29) and the first four-residue truncated peptide Cc-CATH3(5-29) were active in all tested experiments. In contrast, the eight- and twelve-residue truncated variants Cc-CATH3(9-29) and Cc-CATH3(13-29) appeared to have lost activities. Cc-CATH3(1-29) and Cc-CATH3(5-29) possessed antibacterial activity with minimum inhibitory concentrations of 2-4 and 1-2 μM, respectively. For cytotoxicity, Cc-CATH3(1-29) and Cc-CATH3(5-29) displayed cytotoxicity with the IC50 values of 9.33 and 4.93 μM, respectively. Cc-CATH3(5-29) induced greater liposome membranes disruption than Cc-CATH3(1-29) regardless of lipid type and composition. The leakage results of Cc-CATH3(1-29) share a similar trend with that in Cc-CATH3(5-29); they exhibit no preferential binding to anionic phospholipids. In conclusion, the results suggested that the first four residues at the N-terminus "RVRR" is not essential for presenting all test activities. In contrast, residues five to eight of "FWPL" are necessary as the exclusion of this short motif in Cc-CATH3(9-29) and Cc-CATH3(13-29) leads to a loss of activities. This study will be beneficial for further design and development of Cc-CATH3 to be novel antibiotic. | en_US |
dc.identifier.citation | Archives of Pharmacal Research. Vol.38, No.10 (2015), 1839-1849 | en_US |
dc.identifier.doi | 10.1007/s12272-015-0600-0 | en_US |
dc.identifier.issn | 19763786 | en_US |
dc.identifier.issn | 02536269 | en_US |
dc.identifier.other | 2-s2.0-84944150230 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/35366 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84944150230&origin=inward | en_US |
dc.subject | Biochemistry, Genetics and Molecular Biology | en_US |
dc.subject | Chemistry | en_US |
dc.title | Effect of N-terminal truncation on antibacterial activity, cytotoxicity and membrane perturbation activity of Cc-CATH3 | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84944150230&origin=inward | en_US |